Our Leadership Team

Paulla Dennis

Executive Director, Program Strategy, Rare Disease, Pediatrics, Cell and Gene Therapy

Paulla Dennis has been dedicated to rare disease and pediatric clinical research for more than 25 years, specializing in gene therapy for the last 10+ years. She is highly experienced in operational delivery after spending 17 years at a pediatric hospital running the Clinical Research Services group, where she delivered pivotal studies in several rare pediatric disorders inclusive of gene therapies. Paulla has an additional 8 years’ experience in the CRO setting in startup project management as well as in program strategy, delivering rare, pediatric disease and advanced therapies studies.
As Executive Director, Program Strategy, Paulla advises, consults, plans, and directs the design and strategy for prospective and ongoing rare, pediatric, and gene and cell therapy studies. In her current role, she provides strategies and solutions for operational excellence in this complex clinical research setting with a focus on patient and family pathway planning and comprehensive site assessment and educational support.
Paulla has extensive experience in phase 1-4 studies in a global setting, including autosomal, neurological, metabolic, and endocrine diseases. Her key experience areas include rare/ultra-rare disease, pediatrics, gene therapies, and neurological (neuropsychological, neurodegenerative, and neuromuscular) indications.